166 related articles for article (PubMed ID: 30055539)
1. The Wonders of Silk Fibroin Biomaterials in the Treatment of Breast Cancer.
Tulay P; Galam N; Adali T
Crit Rev Eukaryot Gene Expr; 2018; 28(2):129-134. PubMed ID: 30055539
[TBL] [Abstract][Full Text] [Related]
2. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
Subia B; Kundu SC
Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
[TBL] [Abstract][Full Text] [Related]
3. Silk fibroin-derived nanoparticles for biomedical applications.
Mathur AB; Gupta V
Nanomedicine (Lond); 2010 Jul; 5(5):807-20. PubMed ID: 20662650
[TBL] [Abstract][Full Text] [Related]
4. Folate conjugated silk fibroin nanocarriers for targeted drug delivery.
Subia B; Chandra S; Talukdar S; Kundu SC
Integr Biol (Camb); 2014 Feb; 6(2):203-14. PubMed ID: 24345855
[TBL] [Abstract][Full Text] [Related]
5. Milled non-mulberry silk fibroin microparticles as biomaterial for biomedical applications.
Bhardwaj N; Rajkhowa R; Wang X; Devi D
Int J Biol Macromol; 2015 Nov; 81():31-40. PubMed ID: 26226458
[TBL] [Abstract][Full Text] [Related]
6. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.
Subia B; Dey T; Sharma S; Kundu SC
ACS Appl Mater Interfaces; 2015 Feb; 7(4):2269-79. PubMed ID: 25557227
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma.
Li H; Tian J; Wu A; Wang J; Ge C; Sun Z
Int J Nanomedicine; 2016; 11():4373-80. PubMed ID: 27621628
[TBL] [Abstract][Full Text] [Related]
8. Comparing the properties of Bombyx mori silk cocoons against sericin-fibroin regummed biocomposite sheets.
Morin A; Alam P
Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():215-20. PubMed ID: 27157746
[TBL] [Abstract][Full Text] [Related]
9. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB
Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461
[TBL] [Abstract][Full Text] [Related]
10. Silk fibroin for vascular regeneration.
Wang D; Liu H; Fan Y
Microsc Res Tech; 2017 Mar; 80(3):280-290. PubMed ID: 26097014
[TBL] [Abstract][Full Text] [Related]
11. Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer.
Moin A; Wani SUD; Osmani RA; Abu Lila AS; Khafagy ES; Arab HH; Gangadharappa HV; Allam AN
Drug Deliv; 2021 Dec; 28(1):1626-1636. PubMed ID: 34328806
[TBL] [Abstract][Full Text] [Related]
12. Silk fibroin nanoparticle as a novel drug delivery system.
Mottaghitalab F; Farokhi M; Shokrgozar MA; Atyabi F; Hosseinkhani H
J Control Release; 2015 May; 206():161-76. PubMed ID: 25797561
[TBL] [Abstract][Full Text] [Related]
13. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery.
Wu P; Liu Q; Li R; Wang J; Zhen X; Yue G; Wang H; Cui F; Wu F; Yang M; Qian X; Yu L; Jiang X; Liu B
ACS Appl Mater Interfaces; 2013 Dec; 5(23):12638-45. PubMed ID: 24274601
[TBL] [Abstract][Full Text] [Related]
14. Interactions between fibroin and sericin proteins from Antheraea pernyi and Bombyx mori silk fibers.
Du S; Zhang J; Zhou WT; Li QX; Greene GW; Zhu HJ; Li JL; Wang XG
J Colloid Interface Sci; 2016 Sep; 478():316-23. PubMed ID: 27314644
[TBL] [Abstract][Full Text] [Related]
15. Silk fibroin nanoparticles prepared by electrospray as controlled release carriers of cisplatin.
Qu J; Liu Y; Yu Y; Li J; Luo J; Li M
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():166-74. PubMed ID: 25280693
[TBL] [Abstract][Full Text] [Related]
16. Coaxial electrospun aligned tussah silk fibroin nanostructured fiber scaffolds embedded with hydroxyapatite-tussah silk fibroin nanoparticles for bone tissue engineering.
Shao W; He J; Sang F; Ding B; Chen L; Cui S; Li K; Han Q; Tan W
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():342-51. PubMed ID: 26478319
[TBL] [Abstract][Full Text] [Related]
17. Surface modified silk fibroin nanoparticles for improved delivery of doxorubicin: Development, characterization, in-vitro studies.
Pandey V; Haider T; Chandak AR; Chakraborty A; Banerjee S; Soni V
Int J Biol Macromol; 2020 Dec; 164():2018-2027. PubMed ID: 32758604
[TBL] [Abstract][Full Text] [Related]
18. Phase Behaviour and Miscibility Studies of Collagen/Silk Fibroin Macromolecular System in Dilute Solutions and Solid State.
Ghaeli I; de Moraes MA; Beppu MM; Lewandowska K; Sionkowska A; Ferreira-da-Silva F; Ferraz MP; Monteiro FJ
Molecules; 2017 Aug; 22(8):. PubMed ID: 28820488
[TBL] [Abstract][Full Text] [Related]
19. Silk Fibroin-Coated Liposomes as Biomimetic Nanocarrier for Long-Term Release Delivery System in Cancer Therapy.
Suyamud C; Phetdee C; Jaimalai T; Prangkio P
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443524
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer.
Tian Y; Jiang X; Chen X; Shao Z; Yang W
Adv Mater; 2014 Nov; 26(43):7393-8. PubMed ID: 25238148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
